Molecular detection of hepatitis B, hepatitis C, and torque teno viruses in drug users in Saudi Arabia

Journal of Medical Virology

Volumn 81, Issue 8, 2009, Pages 1343-1347

  Alzahrani, Alhusain J ^a   Dela Cruz, Damian M ^b   Obeid, Obeid E ^a   Bukhari, Huda A ^a   Al Qahtani, Ahmed A ^b   Al Ahdal, Mohammed N ^b  

^a IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Drug users; HCV; Mixed infection; TTV

Indexed keywords

NUCLEIC ACID;

ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; DRUG DEPENDENCE; DRUG USE; GENE AMPLIFICATION; GENOME; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SAUDI ARABIA; TORQUE TENO VIRUS; VIRUS DETECTION;

COMORBIDITY; DNA VIRUS INFECTIONS; DRUG USERS; GENOTYPE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; SAUDI ARABIA; SERUM; SUBSTANCE ABUSE, INTRAVENOUS; TORQUE TENO VIRUS;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; TORQUE TENO VIRUS;

EID: 68049115589     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21487     Document Type: Article

References (32)

1. Al-Faleh FZ. 2003. Changing pattern of hepatitis viral infections in Saudi Arabia in the last two decades. Ann Saudi Med 23:361-365.
2. Al-Mozaini MA, Al-Ahdal MN, Kessie G, Cruz DD, Rezeig MA, Al- Shammary FJ. 2006. Molecular epidemiology and genotyping of TT virus isolated from Saudi blood donors and hepatitis patients. Ann Saudi Med 26:444-449. (Pubitemid 46195731)
3. Alzahrani AJ. 2008. Simultaneous derection of hepatitis C virus core antigen and antibodies in Saudi drug users using a novel assay. J Med Virol 80:603-606.
4. Cami J, Farre M. 2003. Drug addiction. N Engl J Med 349:975-986.
5. Chan SW,McOmish F, Holmes EC,DowB,Peutherer JF, Follett E, Yap PL, Simmonds P. 1992. Analysis of a new hepatitis C virus type and its phylogenetic relationships to existing variants. J Gen Virol 73:1131-11411.
6. Choo QL, Richman KM, Han JH, Berger K, Lee C, Dong C, Gallegos C, Coit D, Medina-Selby A, Barr PJ, Weiner AJ, Bradly DW, Kuo G, Huoughton M. 1991. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 88:2451-2455. (Pubitemid 21916435)
7. Davidson F, Simmonds P, Ferguson JC, Jarvis LM, Dow BC, Follet EAC, Seed CRG, Krusius T, Lin C,Medgyesi GA, KiyokawaH,Olim G,Duraisamy G, Cuypers T, Saeed AA, TeoD,Conradie J,Kew MC, Lin M, Nuchaprayoon C, Ndimbie OK, Yap PL. 1995. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 50 non-coding region. J Gen Virol 76:1197-1204.
8. Edlin BR, Kresina TF, Raymond DB, CardenMR, GourevitchMN,Rich JD, Cheever LW, Cargill VA. 2005. Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. Clin Infect Dis 40:S276-S285. (Pubitemid 40490212)
9. Gergely P, Perlc A, Poór G. 2006. Possible pathogenic nature of the recently discovered TT virus: Does it play a role in autoimmune rheumatic diseases. J Aut Rev 3:2-5.
10. Gunther S, Li BC, Miska S, Kruger DH, Meisel H, Will H. 1995. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosupressed patients. J Virol 69:5437-5444.
11. Hino S, Miyata H. 2007. Torque teno virus (TTV): Current status. Rev Med Virol 17:45-57. (Pubitemid 46114124)
12. Hu Y, Al-Moslih MI,AlAli MT, Uzicanin S, PerkinsH,YiQ, Khameneh SR,WuJ, Brown EG. 2008.Clinical outcome of frequent exposure to torque teno virus (ttv) through blood transfusion in thalassemia patients with or without hepatitis c virus (hcv) infection. J Med Virol 80:365-371.
13. Irshad M, Joshi YK, Sharma Y, Dhar I. 2006. Transfusion transmitted virus: A review on its molecular characteristics and role in medicine. World J Gastroenterol 28:5122-5134. (Pubitemid 44355907)
14. Kato H, Orito E, Saugauchi F, Ueda R, Koshizaka T, Yanaka S, Gish RG, Kurbanov F, Ruzibakiev R, Kramvis A, Kew MC, Ahmad N, Khan M, Usuda S, Miyakawa Y, Mizokami M. 2003. Frequent coinfection with hepatitis B virus strains of distinct genotypes detected by hybridization with type-specific probes immobilized on a solid-phase support. J Virol Methods 110:29-35. (Pubitemid 36579156)
15. Mathei C, Buntinx F, van Damme P. 2002. Seroprevalence of hepatitis C markers among intravenous drug users in western European countries: A systematic review. J Viral Hepatol 9:157-173. (Pubitemid 36005513)
16. Morice Y, Cantaloube JF, Beaucourt S, Barbotte L, De Gendt S, Goncales FL, Butterworth L, Cooksley G, Gish RG, Beaugrand M, Fay F, Fay O, Gonzalez JE, Martins RM, Dhumeaux D, Vanderborght B, Stuyver L, Sablon E, de Lamballerie X, Pawlotsky JM. 2006. Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users. J Med Virol 78:1296-1303. (Pubitemid 44387515)
17. Naoumov NV. 1999. Hepatitis C virus infection in Eastern Europe. J Hepatol 31:84-87. (Pubitemid 30002697)
18. Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa Y, Mayumi M. 1997. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun 241:92-97. (Pubitemid 28033544)
19. O'Connor PG, Selwyn PA, Schottenfeld RS. 1994. Medical care for injection-drug users with human immunodeficiency virus infection. N Engl J Med 331:450-459. (Pubitemid 2115193)
20. Odgerel Z, Nho KB, Moon JY, Kee SH, Park KS, Song KJ, Baek LJ, Yeon JE, Byun KS, Lee CH, Song JW. 2003. Complete genome sequence and phylogenetic analysis of hepatitis B virus (HBV) isolates from patients with chronic HBV infection in Korea. J Med Virol 71:499-503. (Pubitemid 37309919)
21. Okamoto H, Akahane Y, Ukita M, Fukuda M, Tsuda F, Miyakawa Y, Mayumi M. 1998. Fecal excretion of a nonenveloped DNA virus (TTV) associated with posttransfusion non-A-G hepatitis. J Med Virol 56:128-132. (Pubitemid 28419273)
22. Okamoto H, Takahashi M, Nishiza T, Ukita M, Fukuda M, Tsuda F, Miyakawa Y, Mayumi M. 1999.Marked genomic heterogeneity and frequent mixed infection of TT virus demonstrated by PCR with primers from coding and noncoding regions. Virology 259:428-436. (Pubitemid 29393392)
23. Osoba AO. 2002. Hepatitis C virus genotypes in Saudi Arabia. Saudi Med J 23:7-12.
24. Quaglioa G, Lugobonia F, Mezzelania P, Des Jarlaisb D, Lechi A. 2005. Hepatitis vaccination among drug users. Vaccine 12:0-45.
25. Saláková M, Nemecek V, König J, Tachezy R. 2004. Age-specific prevalence, transmission and phylogeny of TT virus in the Czech Republic. BMC Infect Dis 4:56-59. (Pubitemid 39637282)
26. Santolamazza M, Delle Monache M, AlvinoA, Bacosi M, D'Innocenzo S, Ciervo U, AntonaciA, Russo F, Miglioresi L, De Angelis A, Ursitti A, Ricci GL. 2001. Multiple viral infections in a group of intravenous drug users: Hepatitis B virus exposure is the risk factor. Eur J Gastroenterol Hepatol 13:1347-1354. (Pubitemid 33111982)
27. Suwannakan H, Tangkijvanich P, Theamboonlers A, Abe K, Poovarawan Y. 2005. A novel recombinant of hepatitisBvirus genotypesG and C isolated from a Thai patient with hepatocellular carcinoma. J Gen Virol 86:3027-3030. (Pubitemid 41555567)
28. Takahashi K, Hoshino H, Ohta Y, Yoshida N, Mishiro S. 1998. Very high prevalence of TT virus (TTV) infection in general population of Japan revealed by a new set of primers. Hepatol Res 12:233-239. (Pubitemid 28470745)
29. TrepoC, Pradat P. 1999.HepatitisCvirus infection in Western Europe. J Hepatol 31:80-83.
30. Yamashiro T, Nagayama K, Enomoto N, Watanabe H, Miyagi T, Nakasone H, Sakugawa H, WatanabeM. 2004. Quantitation of the level of hepatitis delta virus RNA in serum by real-time polymerase chain reaction and its possible correlation with the clinical stage of liver disease. J Infect Dis 189:1151-1157.
31. Zaki Mel-S, el-Hady NA. 2006. Molecular detection of transfusion transmitted virus coinfection with some hepatotropic viruses. Arch Pathol Lab Med 130:1680-1683.
32. Zeng GB, Wen SJ, Wang ZH, Yan L, Sun J, Hou JL. 2004. A novel hepatitis B virus genotyping system by using restriction fragment length polymorphism patterns of S gene amplicon. World J Gastroenterol 10:3132-3136. (Pubitemid 39419873)